Johnson & Johnson's CEO, Joaquin Duato, was elected to chair of the board, the medtech company said Nov. 30.
Mr. Duato will add the chair title in January 2023, and he will replace Alex Gorsky, according to a news release. Mr. Duato has served as CEO since Jan. 3.
"Joaquin’s appointment to the additional role of chair reflects his tremendous 30-year track record at Johnson & Johnson, as well as the board’s thoughtful and engaged approach to succession planning," Anne Mulcahy, lead independent director said in the release. "During Joaquin’s career with the Company, the board has witnessed firsthand his ability to effectively lead, collaborate, and create value for all our stakeholders."